163 related articles for article (PubMed ID: 30926243)
1. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.
Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C
Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243
[TBL] [Abstract][Full Text] [Related]
2. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity.
Gersch M; Wagstaff JL; Toms AV; Graves B; Freund SMV; Komander D
Mol Cell; 2019 May; 74(3):436-451.e7. PubMed ID: 30926242
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of the highly homologous deubiquitinases ubiquitin specific peptidase 25 and 28: Insights into their pathophysiological and therapeutic roles.
Zhou L; Qin B; Yassine DM; Luo M; Liu X; Wang F; Wang Y
Biochem Pharmacol; 2023 Jul; 213():115624. PubMed ID: 37245535
[TBL] [Abstract][Full Text] [Related]
4. The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition.
Denuc A; Bosch-Comas A; Gonzàlez-Duarte R; Marfany G
PLoS One; 2009; 4(5):e5571. PubMed ID: 19440361
[TBL] [Abstract][Full Text] [Related]
5. A quaternary tetramer assembly inhibits the deubiquitinating activity of USP25.
Liu B; Sureda-Gómez M; Zhen Y; Amador V; Reverter D
Nat Commun; 2018 Nov; 9(1):4973. PubMed ID: 30478318
[TBL] [Abstract][Full Text] [Related]
6. USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines.
Wang H; Meng Q; Ding Y; Xiong M; Zhu M; Yang Y; Su H; Gu L; Xu Y; Shi L; Zhou H; Zhang N
FEBS J; 2021 Feb; 288(4):1325-1342. PubMed ID: 32578360
[TBL] [Abstract][Full Text] [Related]
7. Regulation of USP28 deubiquitinating activity by SUMO conjugation.
Zhen Y; Knobel PA; Stracker TH; Reverter D
J Biol Chem; 2014 Dec; 289(50):34838-50. PubMed ID: 25359778
[TBL] [Abstract][Full Text] [Related]
8. Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily.
Wrigley JD; Gavory G; Simpson I; Preston M; Plant H; Bradley J; Goeppert AU; Rozycka E; Davies G; Walsh J; Valentine A; McClelland K; Odrzywol KE; Renshaw J; Boros J; Tart J; Leach L; Nowak T; Ward RA; Harrison T; Andrews DM
ACS Chem Biol; 2017 Dec; 12(12):3113-3125. PubMed ID: 29131570
[TBL] [Abstract][Full Text] [Related]
9. Tandem UIMs confer Lys48 ubiquitin chain substrate preference to deubiquitinase USP25.
Kawaguchi K; Uo K; Tanaka T; Komada M
Sci Rep; 2017 Mar; 7():45037. PubMed ID: 28327663
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alternatively spliced products and tissue-specific isoforms of USP28 and USP25.
Valero R; Bayés M; Francisca Sánchez-Font M; González-Angulo O; Gonzàlez-Duarte R; Marfany G
Genome Biol; 2001; 2(10):RESEARCH0043. PubMed ID: 11597335
[TBL] [Abstract][Full Text] [Related]
11. ¹H, ¹³C and ¹⁵N backbone and side-chain resonance assignments of the N-terminal ubiquitin-binding domains of the human deubiquitinase Usp28.
Wen Y; Cui R; Zhang H; Zhang N
Biomol NMR Assign; 2014 Oct; 8(2):251-4. PubMed ID: 23754699
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the bi-specificity of USP25 and USP28 inhibitors.
Patzke JV; Sauer F; Nair RK; Endres E; Proschak E; Hernandez-Olmos V; Sotriffer C; Kisker C
EMBO Rep; 2024 May; ():. PubMed ID: 38816515
[TBL] [Abstract][Full Text] [Related]
13. Structural and Functional Investigations of the N-Terminal Ubiquitin Binding Region of Usp25.
Yang Y; Shi L; Ding Y; Shi Y; Hu HY; Wen Y; Zhang N
Biophys J; 2017 May; 112(10):2099-2108. PubMed ID: 28538147
[TBL] [Abstract][Full Text] [Related]
14. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
[TBL] [Abstract][Full Text] [Related]
15. USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells.
Karapurkar JK; Colaco JC; Suresh B; Tyagi A; Woo SH; Jo WJ; Ko N; Singh V; Hong SH; Oh SJ; Kim KS; Ramakrishna S
Cell Mol Life Sci; 2024 Mar; 81(1):145. PubMed ID: 38498222
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation.
Cheng H; Li X; Wang C; Chen Y; Li S; Tan J; Tan B; He Y
Cancer Lett; 2019 Feb; 443():80-90. PubMed ID: 30472184
[TBL] [Abstract][Full Text] [Related]
17. USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma.
Ruiz EJ; Pinto-Fernandez A; Turnbull AP; Lan L; Charlton TM; Scott HC; Damianou A; Vere G; Riising EM; Da Costa C; Krajewski WW; Guerin D; Kearns JD; Ioannidis S; Katz M; McKinnon C; O'Connell J; Moncaut N; Rosewell I; Nye E; Jones N; Heride C; Gersch M; Wu M; Dinsmore CJ; Hammonds TR; Kim S; Komander D; Urbe S; Clague MJ; Kessler BM; Behrens A
Elife; 2021 Oct; 10():. PubMed ID: 34636321
[TBL] [Abstract][Full Text] [Related]
18. ¹H, ¹³C and ¹⁵N backbone and side-chain resonance assignments of the N-terminal ubiquitin-binding domains of USP25.
Shi L; Wen Y; Zhang N
Biomol NMR Assign; 2014 Oct; 8(2):255-8. PubMed ID: 23754700
[TBL] [Abstract][Full Text] [Related]
19. A family of unconventional deubiquitinases with modular chain specificity determinants.
Hermanns T; Pichlo C; Woiwode I; Klopffleisch K; Witting KF; Ovaa H; Baumann U; Hofmann K
Nat Commun; 2018 Feb; 9(1):799. PubMed ID: 29476094
[TBL] [Abstract][Full Text] [Related]
20. Computational approach to target USP28 for regulating Myc.
Chakravorty D; Ghosh A; Saha S
Comput Biol Chem; 2020 Apr; 85():107208. PubMed ID: 32028107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
